Astellas
Astellas is a top pharmaceutical company based in Tokyo, Japan Summary Description Examples See Also Astellas is a top pharmaceutical company based in Tokyo, Japan.Astellas was formed on 1 April, 2005...
View ArticleTop 50 Pharma (top pharmaceutical companies)
The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Summary Description Examples See Also 'Top 50 Pharma' is the collective name given to the top pharmaceutical...
View ArticleBig Pharma, Astellas collaborates with Starlight Childeren’s foundation
Big pharma, Astellas is again partnering with Starlight Children's Foundation ("Starlight"), a leading global charity that partners with experts to improve the life and health of kids and families...
View ArticleAstellas pharma signs a pharma alliance with Harvard Medical School
Astellas Pharma announced a pharma alliance with an investigator at Harvard Medical School focused on discovering the pathologic mechanism for retinitis pigmentosa and identification of new therapeutic...
View ArticleQiagen and Astellas form a biotech partnership to develop companion diagnostics
QIAGEN announced a biotech partnership agreement with Astellas Pharma to develop and commercialize companion diagnostics paired with Astellas drugs for use in cancer and other diseases. The scope of...
View ArticleProteostasis signs a pharma deal with Astellas Pharma
Proteostasis Therapeutics announced an R&D and commercialization pharma deal with Tokyo-based Astellas Pharma. The focus of the agreement will be to research and develop compounds that modulate the...
View ArticleAstellas and Janssen terminate ASP015K deal
Astellas Pharma announced that its license agreement with Janssen Biotech, to develop and commercialize ASP015K, oral Janus Kinase (JAK) inhibitor, will end effective January 15, 2015. Janssen has...
View ArticleAstellas and Cytokinetics in $675 million CK-2127107 alliance
Cytokinetics and Astellas Pharma announced an amendment to their collaboration agreement focused on the research, development and commercialization of skeletal muscle activators. The companies have...
View ArticleAstellas licenses allergy vaccine from Immunomic
Immunomic Therapeutics and Astellas Pharma have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax, Immunomic Therapeutics' vaccine designed to treat...
View ArticleVentana and Astellas in automated tissue diagnostics pact
Ventana Medical Systems has entered into master collaboration agreement with Astellas Pharma to develop novel automated tissue diagnostics in support of therapeutic compounds in development. Initial...
View Article